People · Operator
Named in public records as an officer, director or promoter · active 2022–2024 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| EndoSound, Inc. | — | Other Health Care | Seed | $4.7M | $10.2M | 2023 |
| TNA Therapeutics Inc. | — | Biotechnology | Seed | $1.6M | $27.1M | 2022 |
Nicholas Puro at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nicholas Puro on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Tinkham | 1 | 3 |
| Morris Sandler | 1 | 2 |
| Thomas J. Knapp | 1 | 2 |
| Luke Piggott | 1 | 1 |
| William Rhodes | 1 | 1 |
| Scott Corbett | 1 | 1 |
| Stephen Steinberg | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.